1. Khan, I, Ullah, N, Zha, L, et al. (2019) Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome. Pathogens 8(3): 126.
Google Scholar | Crossref2. Yu, LC (2018) Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis. Journal of Biomedical Science 25(1): 79.
Google Scholar | Crossref | Medline3. Corridoni, D, Antanaviciute, A, Gupta, T, et al. (2020) Single-cell atlas of colonic CD8+ T cells in ulcerative colitis. Nature Medicine 26(9): 1480–1490.
Google Scholar | Crossref | Medline4. Crothers, JW, Chu, ND, Nguyen, LTT, et al. (2021) Daily oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study. BMC Gastroenterology 21(1): 281.
Google Scholar | Crossref | Medline5. Horjus Talabur Horje, CS, Middendorp, S, van Koolwijk, E, et al. (2014) Naive T cells in the gut of newly diagnosed, untreated adult patients with inflammatory bowel disease. Inflammatory Bowel Disease 20(11): 1902–1909.
Google Scholar | Crossref | Medline6. Horjus Talabur Horje, CS, Smids, C, Meijer, JW, et al. (2017) High endothelial venules associated with T cell subsets in the inflamed gut of newly diagnosed inflammatory bowel disease patients. Clinical and Experimental Immunology 188(1): 163–173.
Google Scholar | Crossref | Medline7. Hegazy, AN, West, NR, Stubbington, MJT, et al. (2017) Circulating and tissue-resident CD4+ T cells with reactivity to intestinal microbiota are abundant in healthy individuals and function is altered during inflammation. Gastroenterology 153(5): 1320–1337.
Google Scholar | Crossref | Medline8. Schroeder, KW, Tremaine, WJ, Ilstrup, DM (1987) Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. The New England Journal of Medicine 317(26): 1625–1629.
Google Scholar | Crossref | Medline9. Iwamuro, M, Takahashi, T, Watanabe, N, et al. (2020) Technique for single-step lymphocyte isolation from an endoscopic biopsy specimen for the diagnosis of gastrointestinal lymphoma. Methods (Orlando) 7: 101095.
Google Scholar10. Iwamuro, M, Matsueda, K, Takahashi, T, et al. (2020) An endoscopic biopsy specimen contains adequate lymphocytes for flow cytometric analysis of light chain expression in the gastrointestinal mucosa. Annals of Clinical & Laboratory Science 50(3): 348–353.
Google Scholar | Medline11. Matsueda, K, Iwamuro, M, Takahashi, T, et al. (2019) Feasibility of flow cytometric analysis of restricted light chain in endoscopic biopsy specimens from patients with gastrointestinal tract B cell lymphoma: a pilot study. BMC Research Notes 12(1): 571.
Google Scholar | Crossref | Medline12. Ivetic, A, Hoskins Green, HL, Hart, SJ (2019) L-selectin: a major regulator of leukocyte adhesion, migration and signaling. Frontiers in Immunology 10: 1068.
Google Scholar | Crossref | Medline13. Smids, C, Talabur Horje, HCS, Drylewicz, J, et al. (2018) Intestinal T cell profiling in inflammatory bowel disease: linking T cell subsets to disease activity and disease course. Journal of Crohns and Colitis 12(4): 465–475.
Google Scholar | Crossref | Medline14. Saraiva, DP, Jacinto, A, Borralho, P, et al. (2018) HLA-DR in cytotoxic T lymphocytes predicts breast cancer patients’ response to neoadjuvant chemotherapy. Frontiers in Immunology 9: 2605.
Google Scholar | Crossref | Medline15. Cho, YN, Kee, SJ, Lee, SJ, et al. (2011) Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity. Rheumatology 50(6): 1054–1063.
Google Scholar | Crossref | Medline16. Shimamoto, M, Ueno, Y, Tanaka, S, et al. (2007) Selective decrease in colonic CD56(+) T and CD161(+) T cells in the inflamed mucosa of patients with ulcerative colitis. World Journal of Gastroenterology 13(45): 5995–6002.
Google Scholar | Crossref | Medline